With Dove DermaSeries, Unilever Targets Premium Personal-Care Growth
This article was originally published in The Rose Sheet
Executive Summary
Priced at $17.99 and $18.99, the moisturizers in Unilever’s new Dove DermaSeries line are more effective than leading prescription creams, the firm says. The launch is consistent with Unilever’s stated ambition to expand its personal-care portfolio in the premium direction.
You may also be interested in...
Unilever’s “Mature” Personal-Care Biz Inspires Confidence Despite Economy
M&A activity and organic growth have grown Unilever’s personal-care unit into a “mature” business that is gaining share globally while transforming the firm’s U.S. presence, CEO Polman said during a July 24 first-half earnings call. Still, the Anglo-Dutch firm’s personal-care sector struggled in the unstable global environment, with turnover dipping 5.5% in the first half.
Unilever Diversifies Hair-Care Portfolio With $3.7 Bil. Alberto Culver Buy
Unilever says Alberto Culver's product offering will fill out its existing personal-care portfolio, strengthening its hair- and skin-care focus and growing its business in the U.S. and U.K. in particular.
Unilever’s Dove Recommits To ‘Real Women’ Against Rising AI Threat
Unilever PLC’s Dove and Baby Dove brands continue tackling prominent social causes with a vow to be responsible about representing women realistically in advertising in the age of AI and a renewed commitment to closing the Black maternal care gap.